Drugs / Toragesic®
Trials 0
Also used as a comparator or background therapy in 1 trial
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 3 | NCT04647435 Comparator | May 2023 → Oct 2024 | — | Apsen Farmaceutica S.A. | Completed | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | Toragesic | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04647435 ↗ |
| Route | Oral | “Oral tablets every 6h for 3 days” NCT04647435 ↗ |